Skip to main content
. 2020 Mar 18;31(3):153–158. doi: 10.5830/CVJA-2019-064

Table 2. Drugs for rate control.

Drug Route Typical dose Contra-indications References
â-blockers
Metoprolol (tartrate) Oral 25–100 mg, BID Acute pulmonary oedema, heart failure, asthma, severe atrioventricular block and severely depressed patients 17, 28
Metoprolol (succinate) Oral 50–400 mg, QD
Bisoprolol Oral 2.5–10 mg, QD
Atenolol Oral 25–100 mg, QD
ND-CCBs
Diltiazem Oral 120–360 mg QD Severe hypotension, cardiogenic shock, second- or third-degree atrioventricular block or sick sinus syndrome without a pacemaker, patients with left ventricular systolic dysfunction and decompensated heart failure owing to their negative inotropic effects 17, 21, 28
IV 0.25 mg/kg IV bolus over 2 min, then 5–15 mg/h
Verapamil Oral 120–480 mg QD
IV (0.075–0.15 mg/kg) IV bolus over 2 min, then 0.005 mg/kg/min infusion
Digitalis glycosides
Digoxin Oral 0.125–0.25 mg QD Ventricular tachycardia, hypertrophic obstructive cardiomyopathy 17, 21, 28
IV 0.25 mg IV with repeat dosing to a maximum of 1.5 mg over 24 h
Specific indications
Amiodarone Oral 100–200 mg QD Severe sinus node dysfunction, second- or third-degree atrioventricular block or bundle branch disease, syncope caused by bradycardia 21, 28
IV 300 mg IV over 1 h, then 10–50 mg/h over 24 h

QD, once daily; BID, twice daily; IV, intravenous.